# jama.2019.17380

[All years](../README.md) · [Usage](../USAGE.md) · [Codebook](../CODEBOOK.md)

| Paper information | Value |
| --- | --- |
| Version | v.2.2.1 |
| Year | 2019 |
| Paper | jama.2019.17380 |
| Candidates | 7 |
| Based on | v.2.1.5.3 |

[Original paper package](../../../2019/jama.2019.17380/)

## Review setup

Edit the Markdown source. Empty cells mean unanswered. AI suggestions are reference only. All statuses and counts below are maintained manually.

| Field | Value |
| --- | --- |
| Stage | primary |
| Primary reviewer ID |  |
| Primary reviewer name |  |
| Checker ID |  |
| Checker name |  |
| Primary completed on |  |
| Primary backup or revision reference |  |
| Checker completed on |  |
| Paper status | not\_started |

Use `primary` or `checker` for Stage. Use `not_started`, `in_progress`, `primary_ready`, or `final_ready` for Paper status. Follow the [handoff instructions](../USAGE.md#handoff) before starting checking.

## Paper results

Leave final counts blank until every candidate is final. Zero means reviewed and none found. These are candidate counts, not independently deduplicated issue counts.

| Outcome | Final candidate count |
| --- | --- |
| primary\_temporal |  |
| secondary\_temporal |  |
| protocol\_descriptive |  |
| plan\_descriptive |  |
| not\_eligible |  |
| total\_final |  |

## Candidate index

- [C001](#candidate-c001) — Figure 2 omega-3 eGFR contributor counts conflict with Table 2 (S_W)
- [C002](#candidate-c002) — Figure 2 omega-3 urine-ACR contributor counts conflict with eTable 6 (S_C)
- [C003](#candidate-c003) — Figure 3 assigns vitamin-D arm sizes to the opposite column labels (S_W)
- [C004](#candidate-c004) — Figure 4 assigns omega-3 arm sizes to the opposite column labels (S_W)
- [C005](#candidate-c005) — eFigure 2 places vitamin-D participant counts under the opposite headings (S_C)
- [C006](#candidate-c006) — eFigure 3 places omega-3 participant counts under the opposite headings (S_C)
- [C007](#candidate-c007) — Imputation count differs between the analytic-plan addendum and article methods (P_R)

## Candidate C001

**Figure 2 omega-3 eGFR contributor counts conflict with Table 2**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C001 |
| Frozen relationship | S\_W |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Figure 2 panel B — PDF p. 7; Table 2 — PDF p. 8.

### Candidate statement

> Figure 2 panel B and Table 2 print different omega-3 arm-specific eGFR contributor counts at each matched time point.

### AI rationale

> Main Figure2B omega3 eGFR contributor counts differ from main Table2 at all three times while totals match. Abstract/table/figure are sections of one article, despite original cross-document category.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> Figure 2 prints omega-3 placebo 607/459/438 and omega-3 active 701/531/496 at baseline/year 2/year 5. Table 2 prints placebo 651/491/462 and active 657/499/472 for the same outcome, contrast, and time points. Panel B exactly repeats panel A's vitamin-D count sequences.

#### Evidence 1: Reported-versus-comparator

> Figure 2 panel B versus Table 2; the source supplies no distinct panel-B population definition.

#### Evidence 2: Calculation

> Figure minus Table 2 is placebo -44/-32/-24 and active +44/+32/+24; both locations total 1308/990/934 at baseline/year 2/year 5.

#### Evidence 3: Alternative source-grounded interpretations

> An unstated figure-specific subset could have been used, or panel B could retain copied count annotations; neither mechanism is stated in the package.

### Source links

- sourceLinks 0: [Figure 2 panel B — PDF p. 7](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=7)
- sourceLinks 1: [Table 2 — PDF p. 8](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=8)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_W |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity |  |
| broadPlanInvolved | 0 |
| category | Cross-document numeric inconsistency |
| currentReportCrossDocument | 0 |
| id | C001 |
| key | 2019::jama.2019.17380::C001 |
| legacyRelationship |  |
| locations | Figure 2 panel B — PDF p. 7; Table 2 — PDF p. 8. |
| originalCrossDocument | 1 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_W |
| rationale | Main Figure2B omega3 eGFR contributor counts differ from main Table2 at all three times while totals match. Abstract/table/figure are sections of one article, despite original cross-document category. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C001 |
| sourceStatus | Pending Human Adjudication |
| statement | Figure 2 panel B and Table 2 print different omega-3 arm-specific eGFR contributor counts at each matched time point. |
| submissionInvolved | 1 |
| subtype | participant\_count\_mapping |
| suggestedDomain | report\_internal\_inconsistency |
| title | Figure 2 omega-3 eGFR contributor counts conflict with Table 2 |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_W |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C002

**Figure 2 omega-3 urine-ACR contributor counts conflict with eTable 6**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C002 |
| Frozen relationship | S\_C |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Figure 2 panel D — PDF p. 7; eTable 6 — PDF p. 11.

### Candidate statement

> Figure 2 panel D and eTable 6 print different omega-3 arm-specific urine-ACR contributor counts at all matched time points.

### AI rationale

> Main Figure2D omega3 urine-ACR contributor counts differ from the results-supplement eTable6 arm counts at matched times; this is an actual article-versus-results-supplement comparison.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> Figure 2 prints omega-3 placebo 609/463/440 and active 702/529/505; eTable 6 prints placebo 653/490/467 and active 658/502/478. Panel D exactly repeats panel C's vitamin-D sequences.

#### Evidence 1: Reported-versus-comparator

> Figure 2 panel D versus eTable 6 for the same urine-ACR contrast and time points.

#### Evidence 2: Calculation

> Figure minus eTable 6 is placebo -44/-27/-27 and active +44/+27/+27; both locations total 1311/992/945.

#### Evidence 3: Alternative source-grounded interpretations

> An unstated plotting subset is possible; copied panel-C count annotations are also possible but not source-established.

### Source links

- sourceLinks 0: [Figure 2 panel D — PDF p. 7](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=7)
- sourceLinks 1: [eTable 6 — PDF p. 11](../../../2019/jama.2019.17380/joi190122supp2_prod.pdf#page=11)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_C |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity |  |
| broadPlanInvolved | 0 |
| category | Cross-document numeric inconsistency |
| currentReportCrossDocument | 1 |
| id | C002 |
| key | 2019::jama.2019.17380::C002 |
| legacyRelationship |  |
| locations | Figure 2 panel D — PDF p. 7; eTable 6 — PDF p. 11. |
| originalCrossDocument | 1 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_C |
| rationale | Main Figure2D omega3 urine-ACR contributor counts differ from the results-supplement eTable6 arm counts at matched times; this is an actual article-versus-results-supplement comparison. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C002 |
| sourceStatus | Pending Human Adjudication |
| statement | Figure 2 panel D and eTable 6 print different omega-3 arm-specific urine-ACR contributor counts at all matched time points. |
| submissionInvolved | 1 |
| subtype | participant\_count\_mapping |
| suggestedDomain | report\_internal\_inconsistency |
| title | Figure 2 omega-3 urine-ACR contributor counts conflict with eTable 6 |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_C |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C003

**Figure 3 assigns vitamin-D arm sizes to the opposite column labels**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C003 |
| Frozen relationship | S\_W |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Abstract — PDF p. 1; Table 2 and Figure 3 — PDF p. 8.

### Candidate statement

> Figure 3 places the randomized vitamin-D participant counts under the opposite treatment headings; this candidate is confined to participant-count columns.

### AI rationale

> Main Figure3 vitaminD N703/N609 sit under opposite headings relative to the factorial allocations and Table2 inside the same article; candidate is confined to counts.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> Factorial allocations give active vitamin D 370+333=703 and vitamin-D placebo 289+320=609. Figure 3 prints N=703 under Placebo and N=609 under Vitamin D, including the same opposite nested-count mapping.

#### Evidence 1: Reported-versus-comparator

> Figure 3 participant-count columns versus randomized factorial allocation identity and Table 2 treatment labels.

#### Evidence 2: Calculation

> Active vitamin D: 370+333=703; placebo: 289+320=609. Figure 3 assigns 703 to Placebo and 609 to Vitamin D. Its first nested count column 333+370=703 is active vitamin D.

#### Evidence 3: Alternative source-grounded interpretations

> The participant-count columns may be transposed while headings, mean changes, and forest direction remain treatment-aligned. Figure 3's overall changes (-13.1 placebo; -12.3 vitamin D) agree with Table 2 at printed precision.

### Source links

- sourceLinks 0: [Abstract — PDF p. 1](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=1)
- sourceLinks 1: [Table 2 and Figure 3 — PDF p. 8](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=8)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_W |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity |  |
| broadPlanInvolved | 0 |
| category | Measure, label, or scale inconsistency |
| currentReportCrossDocument | 0 |
| id | C003 |
| key | 2019::jama.2019.17380::C003 |
| legacyRelationship |  |
| locations | Abstract — PDF p. 1; Table 2 and Figure 3 — PDF p. 8. |
| originalCrossDocument | 0 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_W |
| rationale | Main Figure3 vitaminD N703/N609 sit under opposite headings relative to the factorial allocations and Table2 inside the same article; candidate is confined to counts. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C003 |
| sourceStatus | Pending Human Adjudication |
| statement | Figure 3 places the randomized vitamin-D participant counts under the opposite treatment headings; this candidate is confined to participant-count columns. |
| submissionInvolved | 1 |
| subtype | arm\_count\_transposition |
| suggestedDomain | report\_internal\_inconsistency |
| title | Figure 3 assigns vitamin-D arm sizes to the opposite column labels |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_W |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C004

**Figure 4 assigns omega-3 arm sizes to the opposite column labels**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C004 |
| Frozen relationship | S\_W |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Abstract — PDF p. 1; Table 2 — PDF p. 8; Figure 4 — PDF p. 9.

### Candidate statement

> Figure 4 places randomized omega-3 participant counts under opposite treatment headings; this candidate is confined to participant-count columns.

### AI rationale

> Main Figure4 omega3 N659/N653 sit under opposite headings relative to main abstract factorial allocation and Table2; no cross-file source is required.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> Factorial allocations give active omega-3 370+289=659 and omega-3 placebo 333+320=653. Figure 4 prints N=659 under Placebo and N=653 under Omega-3 Fatty Acids.

#### Evidence 1: Reported-versus-comparator

> Figure 4 participant-count columns versus factorial allocation identities and Table 2 treatment labels.

#### Evidence 2: Calculation

> Active omega-3: 370+289=659; placebo: 333+320=653. Figure 4 places 659 under Placebo and 653 under Omega-3 Fatty Acids; first nested column 289+370=659 is active omega-3.

#### Evidence 3: Alternative source-grounded interpretations

> N columns may be transposed while headings and mean-change values remain treatment-aligned. The overall Figure 4 changes (-13.1 placebo; -12.2 omega-3) match Table 2 at printed precision.

### Source links

- sourceLinks 0: [Abstract — PDF p. 1](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=1)
- sourceLinks 1: [Table 2 — PDF p. 8](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=8)
- sourceLinks 2: [Figure 4 — PDF p. 9](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=9)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_W |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity |  |
| broadPlanInvolved | 0 |
| category | Measure, label, or scale inconsistency |
| currentReportCrossDocument | 0 |
| id | C004 |
| key | 2019::jama.2019.17380::C004 |
| legacyRelationship |  |
| locations | Abstract — PDF p. 1; Table 2 — PDF p. 8; Figure 4 — PDF p. 9. |
| originalCrossDocument | 0 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_W |
| rationale | Main Figure4 omega3 N659/N653 sit under opposite headings relative to main abstract factorial allocation and Table2; no cross-file source is required. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C004 |
| sourceStatus | Pending Human Adjudication |
| statement | Figure 4 places randomized omega-3 participant counts under opposite treatment headings; this candidate is confined to participant-count columns. |
| submissionInvolved | 1 |
| subtype | arm\_count\_transposition |
| suggestedDomain | report\_internal\_inconsistency |
| title | Figure 4 assigns omega-3 arm sizes to the opposite column labels |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_W |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C005

**eFigure 2 places vitamin-D participant counts under the opposite headings**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C005 |
| Frozen relationship | S\_C |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Abstract — PDF p. 1; eTable 6 — PDF p. 11; eFigure 2 — PDF p. 18.

### Candidate statement

> eFigure 2 maps vitamin-D participant counts to opposite headings while its overall geometric-change values remain aligned with the printed headings; this candidate is count-only.

### AI rationale

> Results-supplement eFigure2 N703/N609 are opposite to exact vitaminD randomized totals derived from main abstract allocation cells. eTable6 in the same supplement also establishes arm identity and matching change ratios; its measured baseline activeN702 cannot fit the figure active randomizedN609.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> eFigure 2 prints Placebo N=703, ratio 3.02, and Active intervention N=609, ratio 2.97. eTable 6 identifies active vitamin D baseline N=702, year-5 ratio 2.97, and placebo N=609, ratio 3.02; randomized totals are 703 active and 609 placebo.

#### Evidence 1: Reported-versus-comparator

> eFigure 2 participant-count columns versus randomized factorial totals and eTable 6 arm-specific values.

#### Evidence 2: Calculation

> Active vitamin D is 370+333=703; placebo is 289+320=609. eFigure 2 places these Ns under opposite headings, while 3.02 placebo and 2.97 active agree with eTable 6. The 703-versus-702 difference is randomized total versus measured baseline availability.

#### Evidence 3: Alternative source-grounded interpretations

> Only the N columns may be transposed; the headings, change values, and forest direction may remain as printed. The source does not establish that any subgroup estimate requires remapping.

### Source links

- sourceLinks 0: [Abstract — PDF p. 1](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=1)
- sourceLinks 1: [eTable 6 — PDF p. 11](../../../2019/jama.2019.17380/joi190122supp2_prod.pdf#page=11)
- sourceLinks 2: [eFigure 2 — PDF p. 18](../../../2019/jama.2019.17380/joi190122supp2_prod.pdf#page=18)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)
- evidencePaths 1: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/verification/evidence\_recheck.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/verification/evidence_recheck.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_C |
| relations | 1 | S\_W |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity | Cross-file exact randomized totals plus within-supplement arm/count compatibility. Randomized703 versus measured702 is an availability difference, not an additional discrepancy; changes/forest estimates are not claimed reversed. |
| broadPlanInvolved | 0 |
| category | Measure, label, or scale inconsistency |
| currentReportCrossDocument | 1 |
| id | C005 |
| key | 2019::jama.2019.17380::C005 |
| legacyRelationship |  |
| locations | Abstract — PDF p. 1; eTable 6 — PDF p. 11; eFigure 2 — PDF p. 18. |
| originalCrossDocument | 0 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_C |
| rationale | Results-supplement eFigure2 N703/N609 are opposite to exact vitaminD randomized totals derived from main abstract allocation cells. eTable6 in the same supplement also establishes arm identity and matching change ratios; its measured baseline activeN702 cannot fit the figure active randomizedN609. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C005 |
| sourceStatus | Pending Human Adjudication |
| statement | eFigure 2 maps vitamin-D participant counts to opposite headings while its overall geometric-change values remain aligned with the printed headings; this candidate is count-only. |
| submissionInvolved | 1 |
| subtype | arm\_count\_transposition |
| suggestedDomain | report\_internal\_inconsistency |
| title | eFigure 2 places vitamin-D participant counts under the opposite headings |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_C |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C006

**eFigure 3 places omega-3 participant counts under the opposite headings**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C006 |
| Frozen relationship | S\_C |
| AI suggested domain | report\_internal\_inconsistency |
| AI suggested disposition | retain |

### Source location

> Abstract — PDF p. 1; eTable 6 — PDF p. 11; eFigure 3 — PDF p. 19.

### Candidate statement

> eFigure 3 maps omega-3 participant counts to opposite headings while overall geometric-change values remain aligned with their printed headings; this candidate is count-only.

### AI rationale

> Results-supplement eFigure3 N659/N653 are opposite to exact omega3 randomized totals derived from main abstract allocation cells. Same-supplement eTable6 identifies active measuredN658 and matching change ratios, incompatible with figure active randomizedN653.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> eFigure 3 prints Placebo N=659, ratio 3.05, and Active intervention N=653, ratio 2.94. eTable 6 identifies active omega-3 baseline N=658, year-5 ratio 2.94, and placebo N=653, ratio 3.05; randomized totals are 659 active and 653 placebo.

#### Evidence 1: Reported-versus-comparator

> eFigure 3 participant-count columns versus randomized factorial totals and eTable 6 arm-specific values.

#### Evidence 2: Calculation

> Active omega-3 is 370+289=659; placebo is 333+320=653. eFigure 3 places those Ns under opposite headings, while 3.05 placebo and 2.94 active agree with eTable 6. The 659-versus-658 difference is randomized total versus measured baseline availability.

#### Evidence 3: Alternative source-grounded interpretations

> N columns may be transposed while headings, changes, and forest direction remain as printed. The supplied comparison does not establish a reversal of all values.

### Source links

- sourceLinks 0: [Abstract — PDF p. 1](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=1)
- sourceLinks 1: [eTable 6 — PDF p. 11](../../../2019/jama.2019.17380/joi190122supp2_prod.pdf#page=11)
- sourceLinks 2: [eFigure 3 — PDF p. 19](../../../2019/jama.2019.17380/joi190122supp2_prod.pdf#page=19)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)
- evidencePaths 1: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/verification/evidence\_recheck.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/verification/evidence_recheck.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | S\_C |
| relations | 1 | S\_W |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity | Cross-file randomized totals plus within-supplement arm/count compatibility. Randomized659 versus measured658 is expected availability context, not a separate discrepancy; effect estimates are not claimed reversed. |
| broadPlanInvolved | 0 |
| category | Measure, label, or scale inconsistency |
| currentReportCrossDocument | 1 |
| id | C006 |
| key | 2019::jama.2019.17380::C006 |
| legacyRelationship |  |
| locations | Abstract — PDF p. 1; eTable 6 — PDF p. 11; eFigure 3 — PDF p. 19. |
| originalCrossDocument | 0 |
| package | jama.2019.17380 |
| planMechanism |  |
| primary | S\_C |
| rationale | Results-supplement eFigure3 N659/N653 are opposite to exact omega3 randomized totals derived from main abstract allocation cells. Same-supplement eTable6 identifies active measuredN658 and matching change ratios, incompatible with figure active randomizedN653. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C006 |
| sourceStatus | Pending Human Adjudication |
| statement | eFigure 3 maps omega-3 participant counts to opposite headings while overall geometric-change values remain aligned with their printed headings; this candidate is count-only. |
| submissionInvolved | 1 |
| subtype | arm\_count\_transposition |
| suggestedDomain | report\_internal\_inconsistency |
| title | eFigure 3 places omega-3 participant counts under the opposite headings |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | S\_C |
| ai\_domain | report\_internal\_inconsistency |
| ai\_disposition | retain |

## Candidate C007

**Imputation count differs between the analytic-plan addendum and article methods**

| Reference | Value |
| --- | --- |
| Candidate key | 2019::jama.2019.17380::C007 |
| Frozen relationship | P\_R |
| AI suggested domain | protocol\_report |
| AI suggested disposition | retain |

### Source location

> Analytic-plan addendum, Section 15c — PDF p. 32; Article Data Analysis — PDF p. 3.

### Candidate statement

> The analytic-plan addendum states 10 imputation data sets, whereas the article methods state implemented multiple imputation M=20.

### AI rationale

> The analytic-plan addendum specifies10 imputation datasets but main implemented Methods reports M20; both use Rubin-rule combination for missing outcomes.

### Human assessment

Fill Primary during initial review. At handoff, preserve Primary and copy its eight answers into Checker / final. Edit only Checker / final during checking. A blank final answer does not inherit a primary answer.

| Field | Primary | Checker / final |
| --- | --- | --- |
| Disposition |  |  |
| Review domain |  |  |
| Statistcal\_or\_numerical issue |  |  |
| Substantiveness |  |  |
| Downstream impact |  |  |
| Report-internal or planning-material inconsistency |  |  |
| Protocol interpretation |  |  |
| Notes (optional) |  |  |
| Complete | no | no |

| Checker record | Value |
| --- | --- |
| Checker result |  |
| Checker comment |  |
| Discussion resolution |  |
| Resolution note |  |
| Final outcome |  |

For `agree`, all eight effective final answers must equal Primary. Other checker results require a comment. `disagree`, `unable`, or a primary `discuss` require resolved discussion and a note naming participants and the conclusion. Leave Final outcome blank until final readiness.

### Evidence

#### Evidence 0: Source evidence

> DOC-002 p. 32 states 10 imputation datasets combined with Rubin's rules. DOC-001 p. 3 states multiple imputation (M = 20) and Rubin-rule combination.

#### Evidence 1: Reported-versus-comparator

> The prospective analytic-plan addendum versus the article's implemented-method description for related missing-outcome analyses.

#### Evidence 2: Calculation

> 20 - 10 = 10; the article reports twice the number of imputation data sets stated in the addendum.

#### Evidence 3: Alternative source-grounded interpretations

> The number of imputations may have been intentionally increased and the analytic scope broadened after the plan text was written. The package does not include a dated change record, rationale, or later governing amendment.

### Source links

- sourceLinks 0: [Analytic-plan addendum, Section 15c — PDF p. 32](../../../2019/jama.2019.17380/joi190122supp1_prod.pdf#page=32)
- sourceLinks 1: [Article Data Analysis — PDF p. 3](../../../2019/jama.2019.17380/jama_de_boer_2019_oi_190122.pdf#page=3)
- evidencePaths 0: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/source\_inventory.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/source_inventory.md)
- evidencePaths 1: [2019/jama.2019.17380/.ai\_paper\_validation/review\_1\_5\_2/verification/evidence\_recheck.md](../../../2019/jama.2019.17380/.ai_paper_validation/review_1_5_2/verification/evidence_recheck.md)

[Original Markdown report](../../../2019/jama.2019.17380/.ai_paper_validation/final_report_1_5_2.md)

### Relationship records

| kind | order | relationship |
| --- | --- | --- |
| relations | 0 | P\_R |

### Source metadata

All catalog fields are preserved below. Historical paths are provenance strings; use the clickable links above to open files.

| Catalog field | Original value |
| --- | --- |
| additionalSensitivityExclude | 0 |
| ambiguity | An intentional increase and broader analytic scope are possible; governing amendment and rationale are absent. |
| broadPlanInvolved | 1 |
| category | Cross-document numeric inconsistency |
| currentReportCrossDocument | 1 |
| id | C007 |
| key | 2019::jama.2019.17380::C007 |
| legacyRelationship |  |
| locations | Analytic-plan addendum, Section 15c — PDF p. 32; Article Data Analysis — PDF p. 3. |
| originalCrossDocument | 1 |
| package | jama.2019.17380 |
| planMechanism | analysis\_specification |
| primary | P\_R |
| rationale | The analytic-plan addendum specifies10 imputation datasets but main implemented Methods reports M20; both use Rubin-rule combination for missing outcomes. |
| reportHref | ../../2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.html |
| reportPath | 2019/jama.2019.17380/.ai\_paper\_validation/final\_report\_1\_5\_2.md |
| sourceId | C007 |
| sourceStatus | Pending Human Adjudication |
| statement | The analytic-plan addendum states 10 imputation data sets, whereas the article methods state implemented multiple imputation M=20. |
| submissionInvolved | 0 |
| subtype | imputation\_count |
| suggestedDomain | protocol\_report |
| title | Imputation count differs between the analytic-plan addendum and article methods |
| year | 2019 |
| ai\_source | meta\_report/consistency\_reclassification\_2026-09-04/reclassified\_candidates.json |
| ai\_relationship | P\_R |
| ai\_domain | protocol\_report |
| ai\_disposition | retain |

## Completion checklist

- [ ] Primary reviewer ID is recorded and every primary assessment is complete.
- [ ] Primary answers were preserved at handoff, with a backup or revision reference recorded.
- [ ] Checker is a different person, with a distinct reviewer ID.
- [ ] Every final assessment uses valid applicable codes and Complete is checker_done.
- [ ] Agreement matches Primary; all other checker results have comments.
- [ ] Required discussions are resolved and participants and conclusions are recorded.
- [ ] No final disposition remains discuss, and every Final outcome follows the codebook.
- [ ] Final counts reconcile to the candidate total and Paper status is final_ready.
